Researchers from New England Biolabs and Yale University have created a system for engineering the first fully synthetic bacteriophages that could help with future clinical development of phage ...

In June, 2025, the Wellcome Trust announced an ambitious £10 million UK project called the Synthetic Human Genome Project (SynHG) and claimed it “will unlock a deeper understanding of life, leading to ...

Medicinal plants produce a wide range of bioactive compounds, yet the genetic and evolutionary mechanisms underlying their ...

An AI model developed by Google's DeepMind could transform our understanding of DNA - the complete recipe for building and running the human body - and its impact on disease and medicine discovery, ...

The Gene Synthesis Market has emerged as one of the most transformative segments within modern biotechnology, driven by rapid ...

The Middle East DNA synthesis market offers opportunities driven by personalized therapies, genomics initiatives, and biotechnology investments. Key growth areas include synthetics in gene editing and ...

Our DNA is made of millions of combinations of the genomes that create the human body. Even the smallest changes in these sequences, or in how they act, can change the functioning of the whole body ...

Genomics and synthetic biology are reshaping healthcare, as rapid DNA sequencing advances power personalized medicine and strong market growth.

ERS Genomics Limited ('ERS'), the CRISPR licensing company, today announced the launch of its Early Access Express License, a ...

Geneticist and entrepreneur Adrian Woolfson argues that genome engineering and AI will let us design organisms beyond nature’s limits ...

ADRIAN WOOLFSON, scientist and founder of Genyro, has authored a brave new book, 'On the Future of Species'. Here, Woolfson examines with SUCHETA DASGUPTA the future of humanity in a world of AI ...